Literature DB >> 26083258

Targeting the cancer cell state.

Kyungjae Myung1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26083258      PMCID： PMC4613985          DOI： 10.1080/15384101.2015.1063294

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

Review 1.  Understanding resistance to EGFR inhibitors-impact on future treatment strategies.

Authors:  Deric L Wheeler; Emily F Dunn; Paul M Harari
Journal:  Nat Rev Clin Oncol       Date:  2010-06-15       Impact factor: 66.675

Review 2.  Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights.

Authors:  Kimberly Ng; Ryan Kim; Santosh Kesari; Bob Carter; Clark C Chen
Journal:  J Neurooncol       Date:  2011-10-16       Impact factor: 4.130

Review 3.  Mechanisms of BCR-ABL in the pathogenesis of chronic myelogenous leukaemia.

Authors:  Ruibao Ren
Journal:  Nat Rev Cancer       Date:  2005-03       Impact factor: 60.716

Review 4.  Oncogene addiction.

Authors:  I Bernard Weinstein; Andrew Joe
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

Review 5.  Key concepts in glioblastoma therapy.

Authors:  Jiri Bartek; Kimberly Ng; Jiri Bartek; Walter Fischer; Bob Carter; Clark C Chen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-03-06       Impact factor: 10.154

6.  Targeting EGFR induced oxidative stress by PARP1 inhibition in glioblastoma therapy.

Authors:  Masayuki Nitta; David Kozono; Richard Kennedy; Jayne Stommel; Kimberly Ng; Pascal O Zinn; Deepa Kushwaha; Santosh Kesari; Maria-del-Mar Inda; Jill Wykosky; Frank Furnari; Katherine A Hoadley; Lynda Chin; Ronald A DePinho; Webster K Cavenee; Alan D'Andrea; Clark C Chen
Journal:  PLoS One       Date:  2010-05-24       Impact factor: 3.240
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.